Europe
Ermium Therapeutics announced a series A funding of €6.3 M with Domain Therapeutics, Kurma Partners, Idinvest, and the SATT Erganeo.
Memo Therapeutics announced that it is entering preclinical development with its first drug candidate an anti-BKV antibody isolated from humans for the treatment of BK virus infection after renal transplantation.
Advanced Medical Solutions Group plc announces its unaudited interim results for the six months ended 30 June 2019.
QuantuMDx Group appoints Neil Butler as a Non-Executive Director
Amphion Innovations plc announces that 1,150,000 shares in Partner Company, Polarean Imaging plc have been sold for partial repayment of the loan facility originally announced on 5 June 2014 and most recently amended as announced on 1 April 2019.
At the Combined General Meeting held on September 5, 2019, in Montpellier, shareholders voted to include the MedinCell “Raison d’être” in the company’s articles of association
Adocia announced that it will deliver an oral presentation covering its ADO09 product at the 55th Annual Meeting of the European Association for the Study of Diabetes, being held September 16-20, 2019 in Barcelona, Spain.
Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines.
Building on its unique six-year relationship with Avalon Ventures, GlaxoSmithKline will acquire San Diego-based Sitari Pharmaceuticals and its transglutaminase 2 small molecule program for celiac disease.
The deal had the upside potential of $1.7 billion but showed mixed results in three Phase III clinical trials. Sanofi announced it had terminated the collaboration, but Lexicon lashed out, alleging Sanofi’s termination was “invalid” and the company was “in breach of contract.”
PRESS RELEASES